Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martelli

Showing results (461-470 of 549) with videos related to

Pageof 55
Sort By:
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
Gastrointestinal surgical emergencies in patients treated for hemathological malignanciesR Caronna, M Cardi, W Arcese, et al.
Cancer Research|September 30, 2010
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemiaFrancesca Chiarini, Cecilia Grimaldi, Francesca Ricci, et al.
Oncotarget|September 23, 2015
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemiaStefano Iacovelli, Maria Rosaria Ricciardi, Matteo Allegretti, et al.
Cell Death & Disease|April 15, 2022
Lamin A and the LINC complex act as potential tumor suppressors in Ewing SarcomaFrancesca Chiarini, Francesca Paganelli, Tommaso Balestra, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Blood|November 24, 1999
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patientsP L Zinzani, M Martelli, M Magagnoli, et al.
Leukemia|September 19, 2008
Targeting the leukemic stem cell: the Holy Grail of leukemia therapyN Misaghian, G Ligresti, L S Steelman, et al.
Oncotarget|April 1, 2015
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered laminsCamilla Evangelisti, Pia Bernasconi, Paola Cavalcante, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Pageof 55

Showing results (461-470 of 549) with videos related to

Sort By:
Pageof 55
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
Gastrointestinal surgical emergencies in patients treated for hemathological malignanciesR Caronna, M Cardi, W Arcese, et al.
Cancer Research|September 30, 2010
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemiaFrancesca Chiarini, Cecilia Grimaldi, Francesca Ricci, et al.
Oncotarget|September 23, 2015
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemiaStefano Iacovelli, Maria Rosaria Ricciardi, Matteo Allegretti, et al.
Cell Death & Disease|April 15, 2022
Lamin A and the LINC complex act as potential tumor suppressors in Ewing SarcomaFrancesca Chiarini, Francesca Paganelli, Tommaso Balestra, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Blood|November 24, 1999
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patientsP L Zinzani, M Martelli, M Magagnoli, et al.
Leukemia|September 19, 2008
Targeting the leukemic stem cell: the Holy Grail of leukemia therapyN Misaghian, G Ligresti, L S Steelman, et al.
Oncotarget|April 1, 2015
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered laminsCamilla Evangelisti, Pia Bernasconi, Paola Cavalcante, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Pageof 55